Without limiting Section 4. 1.2, upon Tandem’s request, DexCom will participate in joint meetings with Tandem with relevant Regulatory Authorities as reasonably necessary to support Regulatory Approval of Combined System Implementations, including, as applicable the Tandem Diabetes Management Apps, but excluding DexCom CGM Apps.
Appears in 1 contract
Without limiting Section 4. 1.2, upon Tandem▇▇▇▇▇▇’s request, DexCom will participate in joint meetings with Tandem with relevant Regulatory Authorities as reasonably necessary to support Regulatory Approval of Combined System ImplementationsSystems, including, as applicable the Tandem Diabetes Management Apps, but excluding DexCom CGM Apps.
Appears in 1 contract
Sources: Commercialization Agreement (Tandem Diabetes Care Inc)
Without limiting Section 4. 1.2, upon Tandem’s request, DexCom will participate in joint meetings with Tandem with relevant Regulatory Authorities as reasonably necessary to support Regulatory Approval of Combined System ImplementationsSystems, including, as applicable the Tandem Diabetes Management Apps, but excluding DexCom CGM Apps.
Appears in 1 contract
Sources: Commercialization Agreement (Tandem Diabetes Care Inc)
Without limiting Section 4. 1.2, upon Tandem▇▇▇▇▇▇’s request, DexCom will participate in joint meetings with Tandem with relevant Regulatory Authorities as reasonably necessary to support Regulatory Approval of Combined System Implementations, including, as applicable the Tandem Diabetes Management Apps, but excluding DexCom CGM Apps.
Appears in 1 contract